Exact Mass: 613.2523

6-Oxoneomycin C

C23H43N5O14 (613.2806)

Ferrioxamine B

C25H45FeN6O8 (613.2648)

Ferrioxamine b belongs to the class of organic compounds known as n-acyl amines. N-acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Ferrioxamine b is considered to be a practically insoluble (in water) and relatively neutral molecule. Ferrioxamine b exists in all living organisms, ranging from bacteria to humans.

Neoacrimarine E

C35H35NO9 (613.2312)

Neoacrimarine E is found in citrus. Neoacrimarine E is an alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) and Dancy tangerine (Citrus tangerina)] (Rutaceae). Alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) and Dancy tangerine (Citrus tangerina)] (Rutaceae). Neoacrimarine E is found in citrus.

Pervilleine D

C32H39NO11 (613.2523)

Guineamide A

C31H43N5O6S (613.2934)

Phoslactomycin C

C30H48NO10P (613.3016)

SCHEMBL1875255

C30H30F7N3O3 (613.2175)

(1alpha,6alpha,14alpha)-8-acetoxy-13-hydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl 4-methoxybenzoate|macrorhynine B

C33H43NO10 (613.2887)

C28H39NO14

C28H39NO14 (613.237)

15-O-methylenigmazole A

C30H48NO10P (613.3016)

C24H39NO17

C24H39NO17 (613.2218)

Myrsinol-type diterpene ester CPB51-719-2

C32H39NO11 (613.2523)

Phe Ile Phe Met Gly

C31H43N5O6S (613.2934)

His Val Thr Glu Glu

C25H39N7O11 (613.2707)

Ferrioxamine B [M+Fe-2H]

C25H45FeN6O8 (613.2648)

Asp Phe Phe Trp

C33H35N5O7 (613.2536)

Asp Phe Trp Phe

C33H35N5O7 (613.2536)

Asp Met Trp Tyr

C29H35N5O8S (613.2206)

Asp Met Tyr Trp

C29H35N5O8S (613.2206)

Asp Trp Phe Phe

C33H35N5O7 (613.2536)

Asp Trp Met Tyr

C29H35N5O8S (613.2206)

Asp Trp Tyr Met

C29H35N5O8S (613.2206)

Asp Tyr Met Trp

C29H35N5O8S (613.2206)

Asp Tyr Trp Met

C29H35N5O8S (613.2206)

Glu Phe Arg Tyr

C29H39N7O8 (613.286)

Glu Phe Tyr Arg

C29H39N7O8 (613.286)

Glu Arg Phe Tyr

C29H39N7O8 (613.286)

Glu Arg Tyr Phe

C29H39N7O8 (613.286)

Glu Tyr Phe Arg

C29H39N7O8 (613.286)

Glu Tyr Arg Phe

C29H39N7O8 (613.286)

Phe Asp Phe Trp

C33H35N5O7 (613.2536)

Phe Asp Trp Phe

C33H35N5O7 (613.2536)

Phe Glu Arg Tyr

C29H39N7O8 (613.286)

Phe Glu Tyr Arg

C29H39N7O8 (613.286)

Phe Phe Asp Trp

C33H35N5O7 (613.2536)

Phe Phe Trp Asp

C33H35N5O7 (613.2536)

Phe Met Met Trp

C30H39N5O5S2 (613.2392)

Phe Met Trp Met

C30H39N5O5S2 (613.2392)

Phe Arg Glu Tyr

C29H39N7O8 (613.286)

Phe Arg Tyr Glu

C29H39N7O8 (613.286)

Phe Val Trp Tyr

C34H39N5O6 (613.29)

Phe Val Tyr Trp

C34H39N5O6 (613.29)

Phe Trp Asp Phe

C33H35N5O7 (613.2536)

Phe Trp Phe Asp

C33H35N5O7 (613.2536)

Phe Trp Met Met

C30H39N5O5S2 (613.2392)

Phe Trp Val Tyr

C34H39N5O6 (613.29)

Phe Trp Tyr Val

C34H39N5O6 (613.29)

Phe Tyr Glu Arg

C29H39N7O8 (613.286)

Phe Tyr Arg Glu

C29H39N7O8 (613.286)

Phe Tyr Val Trp

C34H39N5O6 (613.29)

Phe Tyr Trp Val

C34H39N5O6 (613.29)

Met Asp Trp Tyr

C29H35N5O8S (613.2206)

Met Asp Tyr Trp

C29H35N5O8S (613.2206)

Met Phe Met Trp

C30H39N5O5S2 (613.2392)

Met Phe Trp Met

C30H39N5O5S2 (613.2392)

Met Met Phe Trp

C30H39N5O5S2 (613.2392)

Met Met Trp Phe

C30H39N5O5S2 (613.2392)

Met Trp Asp Tyr

C29H35N5O8S (613.2206)

Met Trp Phe Met

C30H39N5O5S2 (613.2392)

Met Trp Met Phe

C30H39N5O5S2 (613.2392)

Met Trp Tyr Asp

C29H35N5O8S (613.2206)

Met Tyr Asp Trp

C29H35N5O8S (613.2206)

Met Tyr Trp Asp

C29H35N5O8S (613.2206)

Arg Glu Phe Tyr

C29H39N7O8 (613.286)

Arg Glu Tyr Phe

C29H39N7O8 (613.286)

Arg Phe Glu Tyr

C29H39N7O8 (613.286)

Arg Phe Tyr Glu

C29H39N7O8 (613.286)

Arg Tyr Glu Phe

C29H39N7O8 (613.286)

Arg Tyr Phe Glu

C29H39N7O8 (613.286)

Val Phe Trp Tyr

C34H39N5O6 (613.29)

Val Phe Tyr Trp

C34H39N5O6 (613.29)

Val Trp Phe Tyr

C34H39N5O6 (613.29)

Val Trp Tyr Phe

C34H39N5O6 (613.29)

Val Tyr Phe Trp

C34H39N5O6 (613.29)

Val Tyr Trp Phe

C34H39N5O6 (613.29)

Trp Asp Phe Phe

C33H35N5O7 (613.2536)

Trp Asp Met Tyr

C29H35N5O8S (613.2206)

Trp Asp Tyr Met

C29H35N5O8S (613.2206)

Trp Phe Asp Phe

C33H35N5O7 (613.2536)

Trp Phe Phe Asp

C33H35N5O7 (613.2536)

Trp Phe Met Met

C30H39N5O5S2 (613.2392)

Trp Phe Val Tyr

C34H39N5O6 (613.29)

Trp Phe Tyr Val

C34H39N5O6 (613.29)

Trp Met Asp Tyr

C29H35N5O8S (613.2206)

Trp Met Phe Met

C30H39N5O5S2 (613.2392)

Trp Met Met Phe

C30H39N5O5S2 (613.2392)

Trp Met Tyr Asp

C29H35N5O8S (613.2206)

Trp Val Phe Tyr

C34H39N5O6 (613.29)

Trp Val Tyr Phe

C34H39N5O6 (613.29)

Trp Tyr Asp Met

C29H35N5O8S (613.2206)

Trp Tyr Phe Val

C34H39N5O6 (613.29)

Trp Tyr Met Asp

C29H35N5O8S (613.2206)

Trp Tyr Val Phe

C34H39N5O6 (613.29)

Tyr Asp Met Trp

C29H35N5O8S (613.2206)

Tyr Asp Trp Met

C29H35N5O8S (613.2206)

Tyr Glu Phe Arg

C29H39N7O8 (613.286)

Tyr Glu Arg Phe

C29H39N7O8 (613.286)

Tyr Phe Glu Arg

C29H39N7O8 (613.286)

Tyr Phe Arg Glu

C29H39N7O8 (613.286)

Tyr Phe Val Trp

C34H39N5O6 (613.29)

Tyr Phe Trp Val

C34H39N5O6 (613.29)

Tyr Met Asp Trp

C29H35N5O8S (613.2206)

Tyr Met Trp Asp

C29H35N5O8S (613.2206)

Tyr Arg Glu Phe

C29H39N7O8 (613.286)

Tyr Arg Phe Glu

C29H39N7O8 (613.286)

Tyr Val Phe Trp

C34H39N5O6 (613.29)

Tyr Val Trp Phe

C34H39N5O6 (613.29)

Tyr Trp Asp Met

C29H35N5O8S (613.2206)

Tyr Trp Phe Val

C34H39N5O6 (613.29)

Tyr Trp Met Asp

C29H35N5O8S (613.2206)

Tyr Trp Val Phe

C34H39N5O6 (613.29)

FIFMG

C31H43N5O6S (613.2934)

HVTEE

C25H39N7O11 (613.2707)

Neoacrimarine E

C35H35NO9 (613.2312)

Fmoc-Pen(Trt)-OH

C39H35NO4S (613.2287)

TAE684(NVP-TAE684)

C30H40ClN7O3S (613.2602)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

Skinasensyl

C34H39N5O6 (613.29)

Acetyl tetrapeptide-15 is a synthetic peptide used in the cosmetics for sensitive skin. Acetyl tetrapeptide-15 is derived from endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), a human μ-opioid agonist with selective anti-nociceptive effect. Acetyl tetrapeptide-15 reduces skin hyperreactivity producing inflammatory, chronic and neuropathic pain, by increasing the threshold of neuronal excitability in μ-opioid receptor via an endorphin-like pathway[1]. Acetyl tetrapeptide-15 is a synthetic peptide used in the cosmetics for sensitive skin. Acetyl tetrapeptide-15 is derived from endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), a human μ-opioid agonist with selective anti-nociceptive effect. Acetyl tetrapeptide-15 reduces skin hyperreactivity producing inflammatory, chronic and neuropathic pain, by increasing the threshold of neuronal excitability in μ-opioid receptor via an endorphin-like pathway[1].

5-Trt-N6-Bz-rA

C36H31N5O5 (613.2325)

Aplaviroc hydrochloride

C33H44ClN3O6 (613.2918)

C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist

N-(Ethylsulfonyl)-5-propoxy-L-tryptophyl-N~1~-{4-[amino(imino)methyl]benzyl}-L-glutamamide

C29H39N7O6S (613.2682)

N-Acetyl-N-[1-(1,1-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]-4-[difluoro(phosphono)methyl]phenylalaninamide

C31H34F2N3O6P (613.2153)

131-hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester

C35H33MgN4O5- (613.2301)

Euphorbia diterpenoid 2

C32H39NO11 (613.2523)

A tetracyclic diterpenoid isolated from the whole plant of Euphorbia decipiens and exhibits inhibitory activity against urease.

1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea

C31H34F3N5O5 (613.2512)

3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

3-(4-fluorophenyl)-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.2512)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.2512)

N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2258)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.2512)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.2512)

N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2258)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

3-(4-fluorophenyl)-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2258)

N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2258)

N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2258)

N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2258)

N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2258)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2258)

O-[N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosaminyl]-L-threonine

C23H39N3O16 (613.233)

A non-proteinogenic L-alpha-amino acid that is N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine linked via an alpha glycosidic bond to the O at position 3 of L-threonine.

Lnaps 20:5/N-4:0

C30H48NO10P (613.3016)

Lnaps 22:5/N-2:0

C30H48NO10P (613.3016)

Lnaps 2:0/N-22:5

C30H48NO10P (613.3016)

Lnaps 4:0/N-20:5

C30H48NO10P (613.3016)

2-amino-3-[[3-butanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C30H48NO10P (613.3016)

2-amino-3-[[3-hexanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C30H48NO10P (613.3016)

3-[[3-acetyloxy-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C30H48NO10P (613.3016)

Ferroxamine

C25H45FeN6O8 (613.2648)

A Fe(III)-complexed hydroxamate siderophore comprising equimolar amounts of iron(3+) and desferrioxamine B(3-)

6'''-Oxoneomycin C

C23H43N5O14 (613.2806)

Oxoneomycin C

C23H43N5O14 (613.2806)

PE 18:3/7:3;O2

C30H48NO10P (613.3016)

PE 18:4/7:2;O2

C30H48NO10P (613.3016)

PE 20:5/5:1;O2

C30H48NO10P (613.3016)

PE 25:6;O2

C30H48NO10P (613.3016)

LNAPS 23:6;O

C29H44NO11P (613.2652)

LNAPS 24:5

C30H48NO10P (613.3016)

PS 20:4/4:1

C30H48NO10P (613.3016)

PS 20:5/4:0

C30H48NO10P (613.3016)

PS 22:5/2:0

C30H48NO10P (613.3016)

PS 24:5

C30H48NO10P (613.3016)

ST 21:3;O8;HexNAc

C29H43NO13 (613.2734)

ST 25:7;O5;HexNAc

C33H43NO10 (613.2887)

ST 28:4;O7;Tau

C30H47NO10S (613.2921)

methyl (4s)-4-(3-acetyl-2,6-dihydroxyphenyl)-4-(3-{[(2s,5r)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]methyl}-1h-indol-2-yl)-2-methoxybutanoate

C34H35N3O8 (613.2424)

{11-methoxy-9-[2-(3-methoxy-2-methylbut-1-en-1-yl)-1,3-oxazol-4-yl]-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl}oxyphosphonic acid

C30H48NO10P (613.3016)

(3s,6s,7r)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C32H39NO11 (613.2523)

(1s,2r,3r,4r,5s,6s,8r,9r,10r,13s,16s,17r,18r)-8-(acetyloxy)-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-4-yl 4-methoxybenzoate

C33H43NO10 (613.2887)

(2s,5s,8s,11s,14s,15r)-5-benzyl-15-ethyl-4,17-dihydroxy-8-isopropyl-2,6,9,11,14-pentamethyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C31H43N5O6S (613.2934)

[(1e,7e,9e)-3-(2-aminoethyl)-1-(3-ethyl-6-oxo-2,3-dihydropyran-2-yl)-3,6-dihydroxy-10-{3-[(2-methylbutanoyl)oxy]cyclohexyl}deca-1,7,9-trien-4-yl]oxyphosphonic acid

C30H48NO10P (613.3016)

5-benzyl-15-ethyl-4,17-dihydroxy-8-isopropyl-2,6,9,11,14-pentamethyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C31H43N5O6S (613.2934)

(1r,3s,5s,6r,7s)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C32H39NO11 (613.2523)

1-hydroxy-4-[5-hydroxy-2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-3h,4h-pyrano[3,2-g]chromen-4-yl]-3,5,6-trimethoxy-10h-acridin-9-one

C35H35NO9 (613.2312)

(2r,3r,6s,8r,9r,10s,13s,17r)-8-(acetyloxy)-11-formyl-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C33H43NO10 (613.2887)

8-(acetyloxy)-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-4-yl 4-methoxybenzoate

C33H43NO10 (613.2887)

[(1r,3s,4s,6s,9s,11s,15r)-11-methoxy-9-{2-[(1e,3r)-3-methoxy-2-methylbut-1-en-1-yl]-1,3-oxazol-4-yl}-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl]oxyphosphonic acid

C30H48NO10P (613.3016)

6-hydroxy-8-methyl-7-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C32H39NO11 (613.2523)

[(1e,7e,9e)-3-(2-aminoethyl)-1-(3-ethyl-6-oxo-2,3-dihydropyran-2-yl)-3,6-dihydroxy-10-{3-[(3-methylbutanoyl)oxy]cyclohexyl}deca-1,7,9-trien-4-yl]oxyphosphonic acid

C30H48NO10P (613.3016)

1-hydroxy-4-[(4s)-5-hydroxy-2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-3h,4h-pyrano[3,2-g]chromen-4-yl]-3,5,6-trimethoxy-10h-acridin-9-one

C35H35NO9 (613.2312)